EMCDDA Document Library

  Filter by
 

Filter by origin:

Publication date

Category

Main subject

Keywords

Geographical scope

Document language

Displaying 1 - 10 of 15
no image available

Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018 ( (ESCAPE)

January 2021

This study aimed to analyse the residual content of discarded syringes collected across 7 European cities, collectively called the European Syringe Collection and Analysis Project Enterprise (ESCAPE).
document cover

Commission Delegated Directive on isotonitazene

November 2020

Isotonitazene is a synthetic opioid analgesic and is closely related to etonitazene and clonitazene, both of which are under international control under the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol. This document is the Commission Delegated Directive...
Publication cover

COVID-19 and the drug supply chain: from production and trafficking to use (UNODC)

May 2020

This report examines the impact of the COVID-19 pandemic on the illicit drug market. It was prepared by the UNODC Global Research Network and is based on the most recent data from government authorities, open sources, including the media, and the network of UNODC field offices. It should be noted...
Publications thumbnail

An analysis of the costs of dismantling and cleaning up synthetic drug production sites in Belgium and the Netherlands

November 2019

The production of synthetic drugs, measured by the number of manufacturing sites identified and the amount of drugs seized, shows an increasing trend. In the Netherlands, Schoenmakers and Mehlbaum (2017) recorded a rise in the number of sites used for the dumping of toxic waste from synthetic drugs...
no image available

Ministry of Justice, Netherlands (2019) Broad approach to synthetic drugs

July 2019

This document present's the Ministry of Justice, Netherlands' Broad approach to synthetic drugs 2019.
publication cover

World Drug Report 2018

June 2018

The UNODC World Drug Report is published annually and is considered a reference work on the global drug situation. It structured as a a series of five booklets, each focused on a different aspect of the drug problem. The EMCDDA contributes information and data to the report. We strongly recommend...
no image available

Toxicovigilance of synthetic cannabinoids – Perspectives from the EU early warning system

October 2017
no image available

New psychoactive substances: driving greater complexity into the drug problem

August 2016

The appearance of new psychoactive substances (including counterfeit medicines, fentanils and synthetic cannabinoids) increase the challenges faced by drug monitoring systems, health services and policy-makers.
no image available

Council Decision on 4,4′-DMAR and MT-45

October 2015

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats. The substances...
no image available

The European drug landscape in 2013 - highlights from the EMCDDA's European drug report

September 2013

May 2013 saw the publication of the first European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) comprehensive and multi-dimensional package providing information on European drug trends and developments (European Monitoring Centre for Drug and Drug...